Advertisement Sensory Medical raises $2.5 million in series A financing - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Sensory Medical raises $2.5 million in series A financing

Sensory Medical, a medical device company focused on a new treatment for restless legs syndrome has announced the closing of a $2.5 million series A financing.

Salt Creek Medical Device Development (Salt Creek Medical), a medical device company ‘generator’, provided all of the financing through its venture fund, Salt Creek Fund I. The company will use the funds to launch an FDA clinical study on a new device for treatment of restless legs syndrome.

In connection with the series A financing, Jim Voelker, advisor to the Salt Creek Fund I and chairman, CEO and president of InfoSpace, will join Sensory Medical’s board of directors.